ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796,505 | -10.7% | 29,348 | +1.2% | 0.00% | -33.3% |
| Q2 2023 | $891,460 | -19.5% | 29,000 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $1,106,986 | -33.5% | 30,724 | -27.0% | 0.00% | -50.0% |
| Q4 2022 | $1,663,832 | -2.8% | 42,101 | -1.2% | 0.01% | -14.3% |
| Q3 2022 | $1,712,000 | +2.3% | 42,602 | +7.0% | 0.01% | +16.7% |
| Q2 2022 | $1,674,000 | -18.9% | 39,824 | -24.8% | 0.01% | +50.0% |
| Q1 2022 | $2,063,000 | -25.4% | 52,966 | -23.7% | 0.00% | -20.0% |
| Q4 2021 | $2,767,000 | -23.1% | 69,435 | -30.3% | 0.01% | -50.0% |
| Q3 2021 | $3,600,000 | +19.2% | 99,611 | +35.1% | 0.01% | +11.1% |
| Q2 2021 | $3,021,000 | +25.2% | 73,712 | +33.3% | 0.01% | +12.5% |
| Q1 2021 | $2,413,000 | -21.5% | 55,314 | -10.0% | 0.01% | -27.3% |
| Q4 2020 | $3,075,000 | – | 61,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |